Heart Rhythm
Volume 4, Issue 8 , Pages 1009-1012 , August 2007

aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome

Received 28 February 2006 ,Accepted 22 April 2007.

References 

  1. Babaee Bigi MA, Aslani A, Shahrzad S. Prevalence of Brugada sign in patients presenting with palpitation in southern Iran. Europace. 2007;9:252–255
  2. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391–1396
  3. Brugada J, Brugada R, Brugada P. Right bundle branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97:457–460
  4. Brugada J, Brugada R, Antzelevitch C, Towbin JA, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105:73–78
  5. Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K. Brugada syndrome: 1992-2002 a historical review. J Am Coll Cardiol. 2003;41:1665–1671
  6. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293–296
  7. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Brignole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation. 2000;102:2509–2515
  8. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660–1666
  9. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Caradivasc Electrophysiol. 2001;12:268–272
  10. Miyazaki T, Mitamura H, Hiyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27:1061–1070
  11. Chalvidan T, Deharo JC, Dieuzaide P. Near fatal electrical storm in a patient equipped with an implantable cardioverter-defibrillator for Brugada syndrome. PACE. 2000;23:410–412
  12. Eckardt L, Probst V, Smits JP. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257–263
  13. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108:3092–3096
  14. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome. Report of the Second Consensus Conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670.
  15. Alvarez-Gomez JA, Dorantes Sanchez M, Stanley J, Stusser Beltranena R, Castro Hevia J, Barrera Sarduy D, et al. Non-invasive electrical markers in patients with the Brugada syndrome. Arch Cardiol Mex. 2006;76:52–58
  16. Castro Hevia J, Antzelevitch C, Tornés Barzaga F, Dorantes Sanchez M, Dorticos Balea F, Zayas Molina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47:1828–1834
  17. Yamaji H, Iwasaki K, Kusachi S, Murakami T, Hirami R, Hamamoto H, et al. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography: ST segment elevation in lead aVR with less ST-segment elevation in lead V1. J Am Coll Cardiol. 2001;38:1348–1354
  18. Sreeram N, Cheriex EC, Smeets JLRM, Gorgels APM, Wellens HJJ. Value of the 12-lead electrocardiogram at hospital admission in the diagnosis of pulmonary embolism. Am J Cardiol. 1994;73:298–303
  19. Grant AO. Electrophysiological basis and genetics of Brugada syndrome. J Cardiovasc Electrophysiol. 2005;16(suppl 1):S3–S7
  20. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112:2769–2777
  21. Tukkie R, Sogaard P, Vleugels J, de Groot IK, Wilde AA, Tan HL. Delay in right ventricular activation contributes to Brugada syndrome. Circulation. 2004;109:1272–1277
  22. Nagase S, Kusano KF, Morita H, Fujimoto Y, Kakishita M, Nakamura K, et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol. 2002;39:1992–1995
  23. Matsuo K, Shimizu W, Kurita T, Suyama K, Aihara N, Kamakura S, et al. Increased dispersion of repolarization time determined by monophasic action potentials in 2 patients with familial idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1998;9:74–83
  24. Monteban-Kooistra WE, van den Berg MP, Tulleken JE, Ligtenberg JJ, Meertens JH, Zijlstra JG. Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose. Intens Care Med. 2006;32:281–285
  25. Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26:195–201

PII: S1547-5271(07)00506-1

doi: 10.1016/j.hrthm.2007.04.017

Heart Rhythm
Volume 4, Issue 8 , Pages 1009-1012 , August 2007

Article Tools

* Image Usage & Resolution